Increasing evidence indicates that miRNAs regulate aberrant T cell behavior in SLE, modulating key pathogenic mechanisms such as activation of the interferon pathway, DNA hypomethylation, CD40L surface expression, Th17/Treg imbalance, and IL-2 reduction (30). This evidence concerns the gene CD40LG and systemic lupus erythematosus.